J. Helen Cross
Impact in
- Psychiatry and Mental health top 0.01%
- Epilepsy research and treatment
-
- Pharmacological Effects and Toxicity Studies
- Neonatal and fetal brain pathology
Papers in
-
- Epilepsy research and treatment 270
-
- Pharmacological Effects and Toxicity Studies 87
- Neonatal and fetal brain pathology 38
- Co-authors
- Ingrid E. Scheffer (32 shared papers)Jacqueline A. French (16 shared papers)Solomon L. Moshé (15 shared papers)Gary W. Mathern (9 shared papers)Robert S. Fisher (8 shared papers)Jerome Engel (3 shared papers)Sameer M. Zuberi (16 shared papers)Lieven Lagae (27 shared papers)
- Journals
- Epilepsia (98 papers)Developmental Medicine & Child Neurology (33 papers)Epilepsy & Behavior (25 papers)Seizure (19 papers)Neurology (16 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
J. Helen Cross
509 papers receiving 31.3k citations
J. Helen Cross's Hit Papers
Peers
Comparison fields: 5 of 193
- Psychiatry and Mental health 16.1k
- Pediatrics, Perinatology and Child Health 6.1k
- Cellular and Molecular Neuroscience 5.7k
- Clinical Biochemistry 1.8k
- Cognitive Neuroscience 3.5k
Countries citing papers authored by J. Helen Cross
This map shows the geographic impact of J. Helen Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Helen Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Helen Cross more than expected).
Fields of papers citing papers by J. Helen Cross
This network shows the impact of papers produced by J. Helen Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Helen Cross. The network helps show where J. Helen Cross may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Helen Cross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 546 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ILAE Official Report: A practical clinical definition of epilepsy Hit paper breakdown → | 2014 | 3893 |
| 2 | Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009 Hit paper breakdown → | 2010 | 3042 |
| 3 | Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology Hit paper breakdown → | 2017 | 2239 |
| 4 | Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome Hit paper breakdown → | 2017 | 1201 |
| 5 | The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial Hit paper breakdown → | 2008 | 826 |
| 6 | Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders Hit paper breakdown → | 2014 | 706 |
| 7 | Instruction manual for the Hit paper breakdown → | 2017 | 701 |
| 8 | Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome Hit paper breakdown → | 2018 | 681 |
| 9 | ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions Hit paper breakdown → | 2022 | 502 |
| 10 | International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions Hit paper breakdown → | 2022 | 488 |
| 11 | Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors Hit paper breakdown → | 2017 | 391 |
| 12 | The genetic landscape of the epileptic encephalopathies of infancy and childhood Hit paper breakdown → | 2015 | 376 |
| 13 | 2008 | 356 | |
| 14 | 2017 | 346 | |
| 15 | Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome Hit paper breakdown → | 2018 | 341 |
| 16 | Epilepsy surgery in children and adults Hit paper breakdown → | 2014 | 338 |
| 17 | 2008 | 313 | |
| 18 | 2007 | 308 | |
| 19 | 2004 | 294 | |
| 20 | 2014 | 289 |
About J. Helen Cross
J. Helen Cross is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health, Physiology, Molecular Biology and Infectious Diseases, having authored 546 papers that have together received 32.2k indexed citations. Recurring topics across this work include Epilepsy research and treatment (270 papers), Pharmacological Effects and Toxicity Studies (87 papers), Diet and metabolism studies (54 papers), Metabolism and Genetic Disorders (48 papers), Neuroscience and Neuropharmacology Research (44 papers), Neonatal and fetal brain pathology (38 papers), Genetics and Neurodevelopmental Disorders (26 papers) and Parasite Biology and Host Interactions (22 papers). The work is most often cited by research in Psychiatry and Mental health (16.1k citations), Pediatrics, Perinatology and Child Health (6.1k citations), Cellular and Molecular Neuroscience (5.7k citations), Clinical Biochemistry (1.8k citations) and Cognitive Neuroscience (3.5k citations). J. Helen Cross has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Ingrid E. Scheffer, Jacqueline A. French, Solomon L. Moshé, Gary W. Mathern, Robert S. Fisher, Jerome Engel, Sameer M. Zuberi, Lieven Lagae, Alexis Arzimanoglou and Orrin Devinsky. Their work appears in journals such as Epilepsia, Developmental Medicine & Child Neurology, Epilepsy & Behavior, Seizure and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.